How to buy Henry Schein (HSIC) stocks

Henry Schein is a medical distribution business based in the US. Henry Schein shares (HSIC) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $69.94 – a decrease of 4.14% over the previous week. Henry Schein employs 25,000 staff and has a trailing 12-month revenue of around $12.7 billion.

Our top picks for where to buy Henry Schein stock

Buy Henry Schein stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Henry Schein stock price (NASDAQ: HSIC)

Use our graph to track the performance of HSIC stocks over time.

Henry Schein stocks at a glance

• Key figures

Information last updated 2025-03-06.

Latest market close	$69.94
52-week range	$63.67 - $82.49
50-day moving average more info button	$74.23
200-day moving average more info button	$71.25
Wall St. target price	$80.23
PE ratio more info button	23.9213
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$3.05

Is it a good time to buy Henry Schein stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Henry Schein price performance over time

Historical closes compared with the close of $72.92 from 2025-03-11

1 week (2025-03-06)	-0.05%
1 month (2025-02-13)	-6.06%
3 months (2024-12-13)	-4.80%
6 months (2024-09-13)	3.61%

1 year (2024-03-13)	-3.21%
2 years (2023-03-13)	-5.98%
3 years (2022-03-11)	84.17
5 years (2020-03-13)	28.58%

Is Henry Schein stock undervalued or overvalued?

Valuing Henry Schein stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Henry Schein's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Henry Schein's P/E ratio

Henry Schein's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Henry Schein shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

Henry Schein's PEG ratio

Henry Schein's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7692. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Henry Schein's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Henry Schein's EBITDA

Henry Schein's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1 billion.

The EBITDA is a measure of a Henry Schein's overall financial performance and is widely used to measure a its profitability.

Henry Schein financials

Revenue TTM	$12.7 billion
Operating margin TTM	4.86%
Gross profit TTM	$4 billion
Return on assets TTM	4.49%
Return on equity TTM	7.97%
Profit margin	3.08%
Book value	$27.33
Market Capitalization more info button	$9.1 billion

TTM: trailing 12 months

Henry Schein stock dividends

We're not expecting Henry Schein to pay a dividend over the next 12 months.

Have Henry Schein's stocks ever split?

Henry Schein's stocks were split on a 1275:1000 basis on 7 February 2019 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1275 shares. This wouldn't directly have changed the overall worth of your Henry Schein stocks – just the quantity. However, indirectly, the new 21.6% lower stock price could have impacted the market appetite for Henry Schein stocks, which in turn could have impacted Henry Schein's stock price.

Henry Schein stock price volatility

Over the last 12 months, Henry Schein's stocks have ranged in value from as little as $63.67 up to $82.49. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Henry Schein's is 0.902. This would suggest that Henry Schein's stocks are less volatile than average (for this exchange).

Henry Schein overview

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Henry Schein is owned by insiders or institutions?
Currently 1.327% of Henry Schein stocks are held by insiders and 105.863% by institutions. How many people work for Henry Schein?
Latest data suggests 25,000 work at Henry Schein. When does the fiscal year end for Henry Schein?
Henry Schein's fiscal year ends in December. Where is Henry Schein based?
Henry Schein's address is: 135 Duryea Road, Melville, NY, United States, 11747 What is Henry Schein's ISIN number?
Henry Schein's international securities identification number is: US8064071025 What is Henry Schein's CUSIP number?
Henry Schein's Committee on Uniform Securities Identification Procedures number is: 806407102

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.